article thumbnail

Family Physicians Speak Out Against Changes to Vaccine Policy

Minnesota Academy of Family Physicians

AAFP Denounces Changes to ACIP and Vaccine Recommendations The Minnesota Academy of Family Physicians (MAFP) stands with the American Academy of Family Physicians (AAFP) in denouncing the recent decisions made by Health and Human Services (HHS) Secretary, Robert F. Kennedy, Jr.

article thumbnail

Key Bills in the 2025 Legislative Session AAFP is Watching Closely

Alabama Academy of Family Physicians

As the 2025 legislative session swings into full gear, the Alabama Academy of Family Physicians (AAFP) has set its sights on a cadre of pivotal bills set to shape the healthcare landscape for years to come. HB 2 – Vaccine Consent What’s in the Bill: Sponsored by Rep.

Insurance 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Landmark Drug Pricing Bill Set to Become Law; HP&M Releases Summary Slide Deck

FDA Law

Medicare Part D redesign: The IRA changes Medicare Part D starting in 2025 by lowering the patient out-of-pocket (“OOP”) limit to $2,000, adjusted annually in subsequent years. In return for providing the MFP, manufacturers of selected drugs do receive coverage, but high utilization drugs are certain to have coverage anyway.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 2)

FDA Law

Beginning in 2025, payment for certain “Selected” single source drugs under Parts B and D, and under commercial plans that do not opt out of the program, would be limited to a Maximum Fair Price (MFP). The Part B rebate would exclude vaccines as well.

article thumbnail

STATEMENT RELEASE: FDA Task Force Statement on President Trump’s First 100 Days in Office

Doctors for America

FOR IMMEDIATE RELEASE Doctors for America PO Box: 21161 2300 18th St NW Lbby Washington, DC 20009-9996 April 29, 2025 FDA Task Force Statement on President Trump’s First 100 Days in Office WASHINGTON, D.C. We hope that Commissioner Makary will utilize his experience to help ensure FDA puts patients over politics throughout his tenure.